Recovery and half-life of factor VIII

被引：0
作者：
Koc, Basak [1 ,2 ]
Zulfikar, Bulent [1 ,2 ,3 ]
Ozcan, Hanife
机构：
[1] Istanbul Univ, Cerrahpasa Med Fac, Istanbul, Turkey
[2] Inst Oncol, Istanbul, Turkey
[3] Hemophilia Soc Turkey, Istanbul, Turkey
来源：
HAEMOPHILIA | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：52 / 53
页数：2
相关论文
共 50 条
  • [41] Extended half-life recombinant factor VIII treatment of hemophilia A in Brazil: an expert consensus statement
    Ozelo, Margareth Castro
    Antunes, Sandra Vallin
    Villaca, Paula Ribeiro
    Oliveira, Luciana Correa
    Pinto, Ieda Solange
    Lorenzato, Claudia Santos
    Prezotti, Alessandra Nunes Loureiro
    Picoli, Renato Mantelli
    [J]. HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 (01) : 36 - 41
  • [42] Comparison of the Pharmacokinetic Properties of Extended Half-Life and Recombinant Factor VIII Concentrates by In Silico Simulations
    Bukkems, Laura H.
    Preijers, Tim
    van Spengler, Max W. F.
    Leebeek, Frank W. G.
    Cnossen, Marjon H.
    Mathot, Ron A. A.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2021, 121 (06) : 731 - 740
  • [43] PHARMACOKINETIC AND COST CONSIDERATIONS FOR TRANSITION TO EXTENDED HALF-LIFE (EHL) FACTOR VIII AND IX PRODUCTS
    Croteau, Stacy
    Neufeld, Ellis
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : 46 - 46
  • [44] Continuous infusion of extended half-life factor VIII (efmoroctocog alpha) for surgery in severe haemophilia A
    Hovinga, I. C. L. Kremer
    Schutgens, R. E. G.
    van der Valk, P. R.
    van Vulpen, L. F. D.
    Mauser-Bunschoten, E. P.
    Fischer, K.
    [J]. HAEMOPHILIA, 2018, 24 (04) : E280 - E283
  • [45] Extended half-life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products
    Teitel, Jerome
    Sholzberg, Michelle
    Iorio, Alfonso
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (02) : 349 - 355
  • [46] FACTOR-VIII - C RECOVERY AND HALF-LIFE CALCULATED FROM ONE-STAGE ASSAY RESULTS ARE INFLUENCED BY THE DILUTION BUFFER
    HELLSTERN, P
    VONBLOHN, G
    KOHLER, M
    KIEHL, R
    MIYASHITA, C
    WENZEL, E
    [J]. HAEMOSTASIS, 1986, 16 : 98 - 99
  • [47] Pharmacokinetic and Cost Considerations for Transition to Extended Half-life (EHL) Factor VIII and IX Products
    Croteau, S.
    Neufeld, E.
    [J]. HAEMOPHILIA, 2015, 21 (03) : E262 - E262
  • [48] COMPARISON OF RECOVERY AND HALF-LIFE OF A NEW FACTOR-VIII HIGH-PURITY CONCENTRATE (FVIII-C-HS) WITH A FACTOR-VIII-HS (HEMATE-P)
    SCHIMPF, K
    REIS, B
    [J]. RICERCA IN CLINICA E IN LABORATORIO, 1986, 16 (01): : 231 - 231
  • [49] Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies
    Di Minno, Matteo Nicola Dario
    Di Minno, Alessandro
    Calcaterra, Ilenia
    Cimino, Ernesto
    Dell'Aquila, Francesco
    Franchini, Massimo
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2021, 47 (01) : 32 - 42
  • [50] Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies
    Di Minno, Matteo Nicola Dario
    Minno, Alessandro Di
    Calcaterra, Ilenia
    Cimino, Ernesto
    Dell'Aquila, Francesco
    Franchini, Massimo
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2022, 48 (02) : 253 - 255
12345